Page last updated: 2024-11-02

pargyline and Ataxia

pargyline has been researched along with Ataxia in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foster, LL1
Scott, WN1

Other Studies

1 other study available for pargyline and Ataxia

ArticleYear
Observations on the effects of decaborane and several potential antidotes in the rat. SAM-TR-67-103.
    [Technical report] SAM-TR. USAF School of Aerospace Medicine, 1967

    Topics: Animals; Antidotes; Ataxia; Boron Compounds; Male; Methanol; Pargyline; Picolines; Pyridoxine; Rats;

1967